Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Exscientia Plc (Exscientia) is an artificial intelligence-driven pharma tech company. Its primary activities focuses on the use of AI and machine learning systems to automate drug design, with a focus on precision data generation. The company's products are AI-designed molecules, with the company being the first to have such a molecule enter clinical trials. Exscientia's AI-driven drug discovery platform is used to create precision-engineered, patient-centric therapeutic candidates. Its products are primarily used in the healthcare industry, specifically in the area of preclinical drug discovery. Exscientia is headquartered in Oxford, the UK.
Products and Services
| Products | Services |
|---|---|
| GTAEXS617 | AI Drug Discovery |
| EXS4318 | |
| EXS74539 | |
| XYZ | |
| XYZ | |
| XYZ |
Competitor Comparison
| Key Parameters | Exscientia Ltd | Sartorius Albumedix Ltd | Cambridge Biotechnology Ltd (Inactive) | Nutra Green Biotechnology Co Ltd | PharmaKure Ltd |
|---|---|---|---|---|---|
| Headquarters | United Kingdom | United Kingdom | United Kingdom | China | United Kingdom |
| City | Oxford | Nottingham | Liverpool | Shanghai City | Macclesfield |
| State/Province | England | England | England | Shanghai | England |
| No. of Employees | 501 | 106 | - | - | 3 |
| Entity Type | Private | Private | Private | Private | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Elizabeth Crain | Chairman | Executive Board | - | - |
| Ben Taylor | Director; Chief Strategy Officer; Chief Financial Officer | Executive Board | 2020 | - |
| David Hallett | Chief Executive Officer - Interim; Chief Scientific Officer; Director | Executive Board | - | - |
| John Overington | Chief Technology Officer | Senior Management | - | - |
| Caroline Rowland | Chief People Officer | Senior Management | 2022 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer